SKI Market

A+| A| A-|

Indian Indices

Sensex

74,106.85 787.30
( 1.07%)

Global Indices

Nasdaq

46,525.67 -61.07
(-0.13%)

Dow Jones

6,603.69 7.37
(0.11%)

Hang Seng

53,576.26 452.77
(0.85%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

32.9918134

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

30.91

7619.95

EPS(TTM)

Face Value()

Div & Yield %

5.44

0.48

Back

PDS consolidated net profit declines 55.50% in the September 2025 quarter

Oct 28,2025

Net profit of PDS declined 55.50% to Rs 30.03 crore in the quarter ended September 2025 as against Rs 67.48 crore during the previous quarter ended September 2024. Sales rose 3.41% to Rs 3419.17 crore in the quarter ended September 2025 as against Rs 3306.29 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3419.17	3306.29	3
OPM %	3.01	4.35	-
PBDT	88.58	121.64	-27
PBT	55.93	96.29	-42
NP	30.03	67.48	-55

74,106.85 787.30 ( 1.07%)

46,525.67 -61.07 (-0.13%)

6,603.69 7.37 (0.11%)

53,576.26 452.77 (0.85%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)